Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Express Scripts
McKinsey
Merck
Julphar
Chubb
Baxter
Argus Health
Harvard Business School

Generated: January 17, 2018

DrugPatentWatch Database Preview

Clobazam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clobazam and what is the scope of clobazam freedom to operate?

Clobazam
is the generic ingredient in one branded drug marketed by Lundbeck Pharms Llc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for clobazam. One supplier is listed for this compound.
Pharmacology for clobazam
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Mechanism of ActionCytochrome P450 2D6 Inhibitors

US Patents and Regulatory Information for clobazam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc ONFI clobazam SUSPENSION;ORAL 203993-001 Dec 14, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-003 Oct 21, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-001 Oct 21, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam SUSPENSION;ORAL 203993-001 Dec 14, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-003 Oct 21, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-002 Oct 21, 2011 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-002 Oct 21, 2011 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-001 Oct 21, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
UBS
QuintilesIMS
Argus Health
Cipla
Daiichi Sankyo
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot